Novel acetylenic prostaglandin analogs
US4073934A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Apr 16, 1976 |
| Grant date | Feb 14, 1978 |
| Priority date | — |
| Expiry date | Apr 16, 1996 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C405/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Optically active and racemic prostaglandin derivatives of the formula ##STR1## wherein R.sub.1 is --OR.sub.5 ; --NHSO.sub.2 CH.sub.3 ; or --O--CH.sub.2 --U--V; R.sub.5 is hydrogen, alkyl, aryl, or a heterocyclic group; U is a direct bond, carbonyl or carbonyloxy; and V is phenyl substituted by 1-3 phenyl, alkoxy of 1-2 carbon atoms, or halogen, preferably bromine; R.sub.2 is hydrogen or alkyl of 1-5 carbon atoms; R.sub.3 is alkyl, substituted or unsubstituted cycloalkyl, straight-chain or branched alkyl of 1-5 carbon atoms substituted by aryl or substituted aryl, when R.sub.1 is as above; or R.sub.3 is aryl or substituted aryl group when R.sub.1 is --OR.sub.5 ', --NHSO.sub.2 CH.sub.3, or --O--CH.sub.2 --U--V and R.sub.5 ' is aryl or a heterocyclic group and U and V are as above; R.sub.4 is hydrogen or an ether or acyl residue; A is --CH.sub.2 --CH.sub.2 -- or cis--CH.dbd.CH--; B is --CH.sub.2 --CH.sub.2 -- or trans--CH.dbd.CH--; D is a direct bond, oxygen, or sulfur; Z is carbonyl or >CH OR.sub.4 wherein OR.sub.4 is in the .alpha.- or .beta.-position; and X y is ##STR2## when Z is >CH OR.sub.4 --, or ##STR3## or --CH.dbd.CH-- when Z is carbonyl; AND, WHEN R.sub.1 is hydroxy, the ph…
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.